Tuberculosis (TB) is a disease that kills one person every 18 s. TB remains a global threat due to the emergence of drug-resistant Mycobacterium tuberculosis (M.tb) strains and the lack of an efficient vaccine. The ability of M.tb to persist in latency, evade recognition following seroconversion, and establish resistance in vulnerable populations warrants closer examination. Past and current research has primarily focused on examination of the role of alveolar macrophages and dendritic cells during M.tb infection, which are critical in the establishment of the host response during infection. However, emerging evidence indicates that the alveolar epithelium is a harbor for M.tb and critical during progression to active disease. Here we evaluate the relatively unexplored role of the alveolar epithelium as a reservoir and also its capacity to secrete soluble mediators upon M.tb exposure, which influence the extent of infection. We further discuss how the M.tb- alveolar epithelium interaction instigates cell-to-cell crosstalk that regulates the immune balance between a proinflammatory and an immunoregulatory state, thereby prohibiting or allowing the establishment of infection. We propose that consideration of alveolar epithelia provides a more comprehensive understanding of the lung environment in vivo in the context of host defense against M.tb.

Keywords:
Alveolar epithelial cell, Tuberculosis, Lung environment, Innate immunity
1.
World Health Organization: WHO tuberculosis fact sheet 2015. http://www.who.int/mediacentre/factsheets/fs104/en/ (accessed March 20, 2015).
2.
Russell DG: TB comes to a sticky beginning. Nat Med 2001;7:894-895.
3.
Sasindran J, Torrelles JB: Mycobacterium tuberculosis infection and inflammation: what is beneficial for the host and for the bacterium? Front Microbiol 2011;2:1-16.
4.
Bermudez LE, Sangari FJ, Kolonoski P, Petrofsky M, Goodman J: The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells. Infect Immun 2002;70:140-146.
5.
van Golde LM: Synthesis of surfactant lipids in the adult lung. Annu Rev Physiol 1985;47:765-774.
6.
Garcia-Perez BE, Castrejon-Jimenez NS, Luna-Herrera J: The role of non-phagocytic cells in mycobacterial infections; in Cardona PJ (ed): Understanding Tuberculosis - Analyzing the Origin of Mycobacterium tuberculosis Pathogenicity. Rijeka, InTech, 2014, pp 149-178.
7.
McDonough KA, Kress Y: Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect Immun 1995;63:4802-4811.
8.
Castro-Garza J, King CH, Swords WE, Quinn FD: Demonstration of spread by Mycobacterium tuberculosis bacilli in A549 epithelial cell monolayers. FEMS Microbiol Lett 2002;212:145-149.
9.
Dobos KM, Spotts EA, Quinn FD, King CH: Necrosis of lung epithelial cells during infection with Mycobacterium tuberculosis is preceded by cell permeation. Infect Immun 2000;68:6300-6310.
10.
Sato K, Tomioka H, Shimizu T, Gonda T, Ota F, Sano C: Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines. J Infect Dis 2002;185:1139-1147.
11.
Castro-Garza J, Swords WE, Karls RK, Quinn FD: Dual mechanism for Mycobacterium tuberculosis cytotoxicity on lung epithelial cells. Can J Microbiol 2012;58:909-916.
12.
Fine KL, Metcalfe MG, White E, Virji M, Karls RK, Quinn FD: Involvement of the autophagy pathway in trafficking of Mycobacterium tuberculosis bacilli through cultured human type II epithelial cells. Cell Microbiol 2012;14:1402-1414.
13.
Lin Y, Zhang M, Barnes PF: Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun 1998;66:1121-1126.
14.
Wickremasinghe MI, Thomas LH, Friendland JS: Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-κB-dependent network. J Immunol 1999;163:3936-3947.
15.
Bruns H, Stenger S: New insights into the interaction of Mycobacterium tuberculosis and human macrophages. Future Microbiol 2014;9:327-341.
16.
Garcia-Perez BE, Mondragon-Flores R, Luna-Herrera J: Internalization of Mycobacterium tuberculosis by macropinocytosis in non-phagocytic cells. Microb Pathog 2003;35:49-55.
17.
Li Y, Wang Y, Liu X: The role of airway epithelial cells in response to mycobacteria infection. Clin Dev Immunol 2012;2012:791392.
18.
Birkness KA, Deslauriers M, Bartlett JH, White EH, King CH, Quinn FD: An in vitro tissue culture bilayer model to examine early events in Mycobacterium tuberculosis infection. Infect Immun 1999;67:653-658.
19.
Vir P, Gupta D, Agarwal R, Verma I: Immunomodulation of alveolar epithelial cells by Mycobacterium tuberculosis phosphatidylinositol mannosides results in apoptosis. APMIS 2014;122:268-282.
20.
Fehrenbach H: Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2001;2:33-46.
21.
Krishnan N, Robertson BD, Thwaites G: The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2010;90:361-366.
22.
Arcos J, Sasindran SJ, Fujiwara N, Turner J, Schlesinger LS, Torrelles JB: Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection. J Immunol 2011;187:372-381.
23.
Torrelles JB, Azad AK, Henning LN, Carlson TK, Schlesinger LS: Role of C-type lectins in mycobacterial infections. Curr Drug Targets 2008;9:102-112.
24.
Nouailles G, Dorhoi A, Koch M, et al: CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J Clin Invest 2014;124:1268-1282.
25.
Wu L, Guangcun D, Min L, Xiaoming L, Wang Y: Roles of mucosal immunity against Mycobacterium tuberculosis infection. Tuberc Res Treat 2012;2012:1-12.
26.
Chuquimia OD, Petursdottir DH, Periolo N, Fernandez C: Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth. Infect Immun 2013;81:381-389.
27.
Rivas-Santiago B, Schwander SK, Sarabia C, et al: Human β-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect Immun 2005;73:4505-4511.
28.
Bozzano F, Marras F, De MA: Immunology of tuberculosis. Mediterr J Hematol Infect Dis 2014;6:e2014027.
29.
Mayer AK, Dalpke AH: Regulation of local immunity by airway epithelial cells. Arch Immunol Ther Exp (Warsz) 2007;55:353-362.
30.
Lakshminarayanan V, Beno DW, Costa RH, Roebuck KA: Differential regulation of interleukin-8 and intercellular adhesion molecule-1 by H2O2 and tumor necrosis factor-α in endothelial and epithelial cells. J Biol Chem 1997;272:32910-32918.
31.
Hakansson G, Lutay N, Andersson M, et al: Epithelial G protein-coupled receptor kinases regulate the initial inflammatory response during mycobacterial infection. Immunobiology 2013;218:984-994.
32.
Corbiere V, Dirix V, Norrenberg S, Cappello M, Remmelink M, Mascart F: Phenotypic characteristics of human type II alveolar epithelial cells suitable for antigen presentation to T lymphocytes. Respir Res 2011;12:15.
33.
Eghtesad M, Jackson HE, Cunningham AC: Primary human alveolar epithelial cells can elicit the transendothelial migration of CD14+ monocytes and CD3+ lymphocytes. Immunology 2001;102:157-164.
34.
Cunningham AC, Zhang JG, Moy JV, Ali S, Kirby JA: A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells. Immunology 1997;91:458-463.
35.
Lo B, Hansen S, Evans K, Heath JK, Wright JR: Alveolar epithelial type II cells induce T cell tolerance to specific antigen. J Immunol 2008;180:881-888.
36.
Stanciu LA, Bellettato CM, Laza-Stanca V, Coyle AJ, Papi A, Johnston SL: Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J Infect Dis 2006;193:404-412.
37.
Gold MC, Napier RJ, Lewinsohn DM: MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis. Immunol Rev 2015;264:154-166.
38.
Bermudez LE, Goodman J: Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect Immun 1996;64:1400-1406.
39.
Fine-Coulson K, Reaves BJ, Karls RK, Quinn FD: The role of lipid raft aggregation in the infection of type II pneumocytes by Mycobacterium tuberculosis. PLoS One 2012;7:e45028.
40.
Kuo CJ, Bell H, Hsieh CL, Ptak CP, Chang YF: Novel mycobacteria antigen 85 complex binding motif on fibronectin. J Biol Chem 2012;287:1892-1902.
41.
Kuo CJ, Ptak CP, Hsieh CL, Akey BL, Chang YF: Elastin, a novel extracellular matrix protein adhering to mycobacterial antigen 85 complex. J Biol Chem 2013;288:3886-3896.
42.
Kinhikar AG, Vargas D, Li H, et al: Mycobacterium tuberculosis malate synthase is a laminin-binding adhesin. Mol Microbiol 2006;60:999-1013.
43.
Dias AA, Raze D, de Lima CS, et al: Mycobacterial laminin-binding histone-like protein mediates collagen-dependent cytoadherence. Mem Inst Oswaldo Cruz 2012;107(suppl 1):174-182.
44.
Kinhikar AG, Verma I, Chandra D, et al: Potential role for ESAT6 in dissemination of M. tuberculosis via human lung epithelial cells. Mol Microbiol 2010;75:92-106.
45.
Boggaram V, Gottipati KR, Wang X, Samten B: Early secreted antigenic target of 6 kDa (ESAT-6) protein of Mycobacterium tuberculosis induces interleukin-8 (IL-8) expression in lung epithelial cells via protein kinase signaling and reactive oxygen species. J Biol Chem 2013;288:25500-25511.
46.
Zhao W, Schorey JS, Groger R, Allen PM, Brown EJ, Ratliff TL: Characterization of the fibronectin binding motif for a unique mycobacterial fibronectin attachment protein, FAP. J Biol Chem 1999;274:4521-4526.
47.
Torrelles JB: Broadening our view aobut the role of Mycobacterium tuberculosis cell envelope components during infection: a battle for survival; in Cardona PJ (ed): Understanding Tuberculosis - Analyzing the Origin of Mycobacterium tuberculosis Pathogenicity. Rijeka, InTech, 2012, pp 1-46.
48.
Mao P, Wu S, Li J, et al: Human alveolar epithelial type II cells in primary culture. Physiol Rep 2015;3.
49.
Arcos J, Diangelo L, Scordo J, et al: Lung mucosa lining fluid modifies Mycobacterium tuberculosis to reprogram human neutrophil killing mechanisms. J Infect Dis 2015, DOI: 110.1093/infdis/jiv146.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.